[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100303662":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":15,"locations":25,"responsibleParty":47,"collaborators":49,"id":62,"slug":10,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":10,"eligibilityCriteria":67,"healthyVolunteers":63,"sex":68,"minAge":69,"maxAge":70,"enrollmentInfo":71,"targetDuration":10,"studyType":74,"phases":10,"briefSummary":75,"conditions":76,"keywords":10,"overallStatus":28,"whyStopped":10,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"Beijing Institute of Heart, Lung and Blood Vessel Diseases","OTHER",[8,11,13],{"label":9,"type":10,"description":10,"interventionNames":10},"Top third of subjects based levels of selected biomarker.",null,{"label":12,"type":10,"description":10,"interventionNames":10},"Middle third of subjects based levels of selected biomarker.",{"label":14,"type":10,"description":10,"interventionNames":10},"Bottom third ofsubjects based levels of selected biomarker.",[16,21],{"name":17,"role":18,"phone":19,"phoneExt":10,"email":20},"Yuan Wang, PhD","CONTACT","86-010-64456721","wangyuan980510@163.com",{"name":22,"role":18,"phone":23,"phoneExt":10,"email":24},"Xue Wang, MD","+86 010-64456721","snowlove_@126.com",[26],{"facility":27,"status":28,"city":29,"state":30,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"Beijing Anzhen Hospital","RECRUITING","Beijing","Beijing Municipality","100029","China","CN",{"type":35,"coordinates":36},"Point",[37,38],116.39723,39.9075,{"lat":38,"lon":37},[41,44],{"name":42,"role":18,"phone":43,"phoneExt":10,"email":20},"Yuan WANG, PhD","86-010-64456169",{"name":45,"role":46,"phone":10,"phoneExt":10,"email":10},"Jie DU, PhD","PRINCIPAL_INVESTIGATOR",{"type":48,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[50,52,54,56,58,60],{"name":51,"class":6},"Beijing Luhe Hospital",{"name":53,"class":6},"The First Affiliated Hospital of Dalian Medical University",{"name":55,"class":6},"The First Hospital of Jilin University",{"name":57,"class":6},"First Affiliated Hospital, Sun Yat-Sen University",{"name":59,"class":6},"The General Hospital of Northern Theater Command",{"name":61,"class":6},"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","100303662",false,"NCT03233087","Diagnosis and Prognosis for Aortic Aneurysm aNd Dissection in Anzhen(DPANDA) Study","Diagnosis and Prognosis for Aortic Aneurysm aNd Dissection in Anzhen","Inclusion Criteria:\n\nRetrospective\n\n* All patients who were referred to the surgical service for evaluation and management of aortic dissection were included.\n\nPerspective\n\n* Patients with initial suspicion of having AAD were perspectively enrolled.\n\nExclusion Criteria:\n\nRetrospective\n\n* Patients who received packed red blood cells, whole blood, or platelets less than 10 days before the blood sample was taken;\n* Patients with aortic trauma, pseudo aneurysm, history of heart failure, renal dysfunction, severe pulmonary diseases, or active cancer;\n* Patients who entered the hospital for checkups after surgery.\n\nPerspective\n\n* Patients in whom there is little or no suspicion of a life-threatening disease;\n* Patients with confirmed acute myocardial infarction,angina or pulmonary embolism\n* The symptoms were clearly not related to AD (e.g. pleurisy, pneumonia, acute abdominal diseases).","ALL","18 Years","80 Years",{"count":72,"type":73},1500,"ESTIMATED","OBSERVATIONAL","The registry study aims to determine serial biomarkers to diagnosis and prognosis of aortic aneurysm\u002Faortic dissection.",[77,78],"Aortic Aneurysm","Aortic Dissection","2024-06-26",{"date":81,"type":82},"2024-06-27","ACTUAL",{"date":84,"type":82},"2014-03-01",{"date":86,"type":73},"2028-12-31",{"name":5,"class":6},1]